Search

Your search keyword '"Langmuir P"' showing total 492 results

Search Constraints

Start Over You searched for: Author "Langmuir P" Remove constraint Author: "Langmuir P"
492 results on '"Langmuir P"'

Search Results

1. One size doesn’t fit all: methodological reflections in conducting community-based behavioural science research to tailor COVID-19 vaccination initiatives for public health priority populations

2. Applying Implementation Science to Identify Primary Care Providers’ Enablers and Barriers to Using Survivorship Care Plans

Catalog

Books, media, physical & digital resources

3. One size doesn’t fit all: methodological reflections in conducting community-based behavioural science research to tailor COVID-19 vaccination initiatives for public health priority populations

4. High-resolution decadal-scale eruption age dating of young oceanic basalts at an active hydrothermal vent site

5. Systematic Review of Longitudinal Evidence and Methodologies for Research on Neighborhood Characteristics and Brain Health

6. A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

7. Treatment Case Studies in the Consolidation and Adhesion of Cellulose Nitrate.

8. A subduction influence on ocean ridge basalts outside the Pacific subduction shield

9. Glacial cycles drive variations in the production of oceanic crust

10. JAK inhibitors and COVID-19

11. Magma and Mineral Composition Response to Increasing Slab-Derived Fluid Flux: Nevado de Longaví Volcano, Southern Chilean Andes

16. Interpreting Charles Lamb’s ‘Neat-Bound Books’

20. Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses

23. The Experience of Trauma Recovery: A Qualitative Study of Participants in the Women Recovering from Abuse Program (WRAP)

24. P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CITADEL-102)

25. P1102: A PHASE 1 STUDY OF PARSACLISIB IN COMBINATION WITH RITUXIMAB, BENDAMUSTINE + RITUXIMAB, OR IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B-CELL LYMPHOMA (CITADEL-112): PRELIMINARY SAFETY RESULTS

26. Links from Mantle to Microbe at the Lau Integrated Study Site: Insights from a Back-Arc Spreading Center

28. Cross-Validation.

31. P-113 FIGHT-302: Phase 3 study of first-line pemigatinib vs gemcitabine + cisplatin for cholangiocarcinoma with FGFR2 fusions or rearrangement

33. Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease

36. THE QUEEN OF TRUE CRIME.

43. WHY MOMMY TROLLS.

48. Female Gaze.

50. The artists, creators, advocates, and rule-breakers who helped us progress in 2019.